Overview
Michinori Ogura practices in Nagoya, Japan. Ogura is rated as a Distinguished expert by MediFind in the treatment of Peripheral T-Cell Lymphoma. Their top areas of expertise are Non-Hodgkin Lymphoma, Peripheral T-Cell Lymphoma, Mantle Cell Lymphoma (MCL), and B-Cell Lymphoma.
Their clinical research consists of co-authoring 116 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 7 articles in the study of Peripheral T-Cell Lymphoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Non-Hodgkin Lymphoma
- Distinguished
- AgranulocytosisOgura isDistinguished. Learn about Agranulocytosis.
- B-Cell LymphomaOgura isDistinguished. Learn about B-Cell Lymphoma.
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Follicular LymphomaOgura isDistinguished. Learn about Follicular Lymphoma.
- Mantle Cell Lymphoma (MCL)Ogura isDistinguished. Learn about Mantle Cell Lymphoma (MCL).
- Peripheral T-Cell LymphomaOgura isDistinguished. Learn about Peripheral T-Cell Lymphoma.
- Advanced
- Chronic Familial Neutropenia
- Febrile NeutropeniaOgura isAdvanced. Learn about Febrile Neutropenia.
- Small Lymphocytic Lymphoma (SLL)
- Experienced
- Adult T-Cell LeukemiaOgura isExperienced. Learn about Adult T-Cell Leukemia.
- Anaplastic Large Cell Lymphoma
- Chronic B-Cell Leukemia (CBCL)
- Chronic Lymphocytic Leukemia (CLL)
- Chronic Myelogenous Leukemia (CML)
- Chronic Myelomonocytic Leukemia (CMML)